About Phibro Animal Health Corporation
Phibro Animal Health Corporation (Phibro) is a global diversified animal health and mineral nutrition company. The Company operates in three segments, which include Animal Health, Mineral Nutrition and Performance Products. The Company offers various products, which include Animal health products, such as antibacterials, anticoccidials, vaccines, nutritional specialty products and mineral nutrition products. The Company also manufactures and markets specific ingredients for use in the personal care, automotive, industrial chemical and chemical catalyst industries. The Company's Medicated Feed Additives (MFAs) and other business consist of concentrated medicated products, which are administered through animal feeds. The Company's MFAs and other business consists of the production and sale of antibacterials, including Stafac, Terramycin, Neo-Terramycin and Mecadox and anticoccidials, including Nicarb, Aviax, Aviax Plus, Coxistac and amprolium.
Industry, Sector and Symbol:
- Sector: Medical
- Industry: Specialized Health Services
- Sub-Industry: N/A
- Exchange: NASDAQ
- Symbol: PAHC
- Previous Close: $29.15
- 50 Day Moving Average: $28.48
- 200 Day Moving Average: $26.66
- 52-Week Range: $16.80 - $30.85
- Trailing P/E Ratio: 19.56
- Foreward P/E Ratio: 19.18
- P/E Growth: 4.52
- Market Cap: $1.15B
- Outstanding Shares: 39,417,000
- Beta: 1.34
- Net Margins: 7.90%
- Return on Equity: 63.70%
- Return on Assets: 10.21%
Companies Related to Phibro Animal Health Corporation:
- Debt-to-Equity Ratio: 2.89%
- Current Ratio: 3.28%
- Quick Ratio: 1.74%
What is Phibro Animal Health Corporation's stock symbol?
Phibro Animal Health Corporation trades on the NASDAQ under the ticker symbol "PAHC."
How often does Phibro Animal Health Corporation pay dividends? What is the dividend yield for Phibro Animal Health Corporation?
Phibro Animal Health Corporation declared a quarterly dividend on Tuesday, February 7th. Shareholders of record on Wednesday, March 1st will be given a dividend of $0.10 per share on Wednesday, March 22nd. This represents a $0.40 dividend on an annualized basis and a yield of 1.37%. The ex-dividend date is Monday, February 27th.
Where is Phibro Animal Health Corporation's stock going? Where will Phibro Animal Health Corporation's stock price be in 2017?
6 brokerages have issued 12-month price objectives for Phibro Animal Health Corporation's shares. Their predictions range from $21.00 to $34.00. On average, they expect Phibro Animal Health Corporation's stock price to reach $27.40 in the next twelve months.
When will Phibro Animal Health Corporation announce their earnings?
Phibro Animal Health Corporation is scheduled to release their next quarterly earnings announcement on Monday, May, 8th 2017.
What are analysts saying about Phibro Animal Health Corporation stock?
Here are some recent quotes from research analysts about Phibro Animal Health Corporation stock:
- Piper Jaffray Companies analysts commented, "We continue to favor shares of PAHC as a top small cap idea in our ag space, where we see potential for upward revisions to guidance in 2H17 following the 2Q earnings beat and management reaffirming guidance. Positively, the Animal Health segment grew in the December-ending quarter despite ongoing headwinds in MFAs, supporting our thesis around the resilience of the animal health industry. We are lifting our FY17 EPS estimate to $1.45 at the top of the guidance range and we see potential earnings upside in 2H17 from growth outside of MFAs and in other geographies like Brazil. We see multiple expansion opportunity with some of the MFA overhang on the stock removed after the resilient 2Q results and our price target moves to $34 based on 21X FY18E EPS of $1.60. We reiterate our Overweight rating." (2/8/2017)
According to Zacks Investment Research, "Phibro ended the fourth quarter of 2016 on an unsatisfactory note with deteriorating earnings on a year-over-year basis. However, the company successfully managed to beat the Zacks Consensus Estimate in both counts posting a top-line improvement, courtesy Animal Health and Performance Products segments. Meanwhile, Phibro sells the bulk of its products to a diverse number and variety of customers. Significant consolidation of the company’s customers might increase the product pricing pressures challenging Phibro’s business. Additionally, currency headwinds, sluggish macro economic conditions and a tough competitive scenario also continue to hurt growth." (11/2/2016)
Who owns Phibro Animal Health Corporation stock?
Phibro Animal Health Corporation's stock is owned by many different of retail and institutional investors. Top institutional shareholders include RidgeWorth Capital Management LLC (3.09%), Foresters Investment Management Company Inc. (3.03%), Thornburg Investment Management Inc. (2.54%), Denver Investment Advisors LLC (1.88%), State Street Corp (1.17%) and FMR LLC (1.12%). Company insiders that own Phibro Animal Health Corporation stock include Bfi Co, Llc, Daniel A Welch, Dean J Warras, E Thomas Corcoran, Gerald K Carlson, Jack Bendheim, Larry Lee Miller and Thomas G Dagger.
Who sold Phibro Animal Health Corporation stock? Who is selling Phibro Animal Health Corporation stock?
Phibro Animal Health Corporation's stock was sold by a variety of institutional investors in the last quarter, including Thornburg Investment Management Inc., FMR LLC, Hotchkis & Wiley Capital Management LLC, Denver Investment Advisors LLC, Janus Capital Management LLC, GSA Capital Partners LLP, AQR Capital Management LLC and RidgeWorth Capital Management LLC. Company insiders that have sold Phibro Animal Health Corporation stock in the last year include Daniel A Welch, Gerald K Carlson, Larry Lee Miller and Thomas G Dagger.
Who bought Phibro Animal Health Corporation stock? Who is buying Phibro Animal Health Corporation stock?
Phibro Animal Health Corporation's stock was purchased by a variety of institutional investors in the last quarter, including Trexquant Investment LP, Paradigm Asset Management Co. LLC, Dimensional Fund Advisors LP, Menta Capital LLC, Renaissance Technologies LLC, Tudor Investment Corp Et Al, Two Sigma Investments LP and Foresters Investment Management Company Inc..
How do I buy Phibro Animal Health Corporation stock?
Shares of Phibro Animal Health Corporation can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
How much does a share of Phibro Animal Health Corporation stock cost?
One share of Phibro Animal Health Corporation stock can currently be purchased for approximately $29.15.